GlassScriptPhysician profile
Boris Shwartzman
NPI 1598766081
$13,512.43
in general payments reported to CMS, 2019-2025
46 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $286 · 2021: $999 · 2022: $3,593 · 2023: $3,582 · 2024: $3,146 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,354 · Travel and Lodging: $2,488 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,353.94 |
| Travel and Lodging | $2,487.75 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $3,720.08 | 2023-2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $2,654.21 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Relievant Medsystems, INC. | $1,230.21 | 2019-2023 | Intracept |
| Boston Scientific Corporation | $889.53 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $644.03 | 2019-2025 | Relistor |
| Nevro Corp. | $383.68 | 2019-2024 | Senza |
| Abbvie INC. | $319.76 | 2021-2025 | Botox |
| Collegium Pharmaceutical, INC. | $316.61 | 2019-2025 | Xtampza |
| Scilex Pharmaceuticals INC. | $294.46 | 2019-2024 | Ztlido |
| Curonix LLC | $281.56 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $263.36 | 2019-2024 | |
| Vertos Medical, INC. | $222.15 | 2019-2024 | Mild Device Kit |
| Abbott Laboratories | $216.57 | 2022-2024 | Octrode, Eterna, Ionicrf |
| Saluda Medical Americas, INC. | $186.14 | 2024 | Evoke |
| Valinor Pharma, LLC | $182.24 | 2023-2025 | Movantik |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Shwartzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.